Abstract
THU-198 - Cross-sectional assessment of >20,000 clinical samples submitted for HCV NS3/4A protease inhibitor drug resistance testing in the US
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have